Using digital health technologies for assessment of people with Parkinson’s

FHS
July 7, 2023
1:02 am

Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson’s.

Novel Drug Effective Against MASH in Phase II Trial

An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic dysfunction-associated steatohepatitis (MASH) in a phase II clinical trial. In

October 15, 2024

Inflammatory diets raise dementia and Alzheimer’s risk

This research study links higher Dietary Inflammatory Index (DII) scores to an increased risk of developing dementia, specifically Alzheimer’s disease. The findings suggest that anti-inflammatory

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Using digital health technologies for assessment of people with Parkinson’s

Social Security chief orders broad review of benefit overpayments

Novel Drug Effective Against MASH in Phase II Trial

Inflammatory diets raise dementia and Alzheimer’s risk

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe